Jan Olav Frederic Rivelsrud • 1982 • Oslo • 12 roles

Roles

Name	Role	Total operating income	Total equity	Shares
R RIVELSRUD AS	Managing Director/CEO	-	23,888,252	100 % directly
A AEON BIOTECH AS	Managing Director/CEO	113,020	-131,438	80 % indirectly
L LEVIDA AS	Managing Director/CEO	-	-	-

Name	Role	Total operating income	Total equity	Shares
R RIVELSRUD AS	Chairman	-	23,888,252	100 % directly
A AEON BIOTECH AS	Chairman	113,020	-131,438	80 % indirectly
C CORTEX CAPITAL AS Closed	Deputy Chair	-	94,423	50 % indirectly
T TANNHELSEGRUPPEN HOLDING AS Closed	Chairman	-	84,423	50 % indirectly
T TANNHELSEGRUPPEN AS Closed	Chairman	-	69,950	50 % indirectly
K KLINIKK.NO AS	Chairman	-	-943,593	33.3 % indirectly
D DR. FREDERIC RIVELSRUD	Holder	-	-	-
L LEVIDA AS	Chairman	-	-	-
O OSCARHOF AS	Board Member	-	-	-

Last update: Sep 18, 2025

Name	Share class	Total operating income	Total equity	Share
R RIVELSRUD AS	Ordinære aksjer	0	23,888,252	100 % directly
A AEON BIOTECH AS		113,020	-131,438	80 % indirectly
C CORTEX CAPITAL AS Closed		0	94,423	50 % indirectly
T TANNHELSEGRUPPEN HOLDING AS Closed		0	84,423	50 % indirectly
T TANNHELSEGRUPPEN AS Closed		0	69,950	50 % indirectly
K KLINIKK.NO AS		0	-943,593	33.3 % indirectly
S STØTTEHJULET AS		0	776,125	12.78 % indirectly
D DISRUPTØREN NUCLEAR 1 AS		0	3,459,559	7.81 % indirectly
H HELLINGA TERRASSE AS Under liquidation		0	-79,710	2.65 % indirectly
A AREALO GRUPPEN AS Under liquidation		500,000	14,786,036	2.65 % indirectly
H HYAS EIENDOM AS Closed		0	-12,571,146	2.65 % indirectly
S SOLTRØA AS Closed		0	-364,106	2.65 % indirectly
B BRÅNÅSLIA PARK AS Closed		0	-977,980	2.65 % indirectly
N ND 17 UTVIKLING AS Under liquidation		0	1,535,879	2.63 % indirectly
A AREALO TECH AS Closed		0	-115,733	2.47 % indirectly
A AMBR INSTITUTE AS		0	1,528,262	2.01 % indirectly
B B35 UTVIKLING AS Closed		0	-6,379,424	1.38 % indirectly
F FOUNDERS & FOOLS DEAL 5 AS		3,168	1,075,446	1.13 % indirectly
S SOLÅSEN UTVIKLING AS		0	1,714,897	0.96 % indirectly
C CORRELATE AS		60,832	28,627,306	0.73 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025